维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="HARTGE P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Performance of common genetic variants in breast-cancer risk models 显示文摘	Wacholder S Hartge P Prentice R	2010	N Engl J Med2010，362，11：	1
2	The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews显示文摘	Hartge P Wacholder S	1997	N Engl J Med1997，336，20：	1
3	Population- based study of riskQ of breast cancer in carriers of BRCA2 mutation 显示文摘	Struewing JP Hartge P ET AL	1998	Lancet1998，352，9137：	1
4	Epidemiological characteristic of squamous cell carcinoma and adenocarcinoma of the bladder显示文摘	Kantor AF Hartge P Hoove RN	1998	Cancer Res1998，48，13：	1
5	Genes, hormones, and pathways to breast cancer显示文摘	Hartge P	2003	N EnglJ Med2003，348，23：	1
6	Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation 显示文摘	Modan B Hartge P Yechezkel G	2001	N Engl J Med2001，26，345：	1
7	Cigarette smoking and risk of non-Hodgkin lymphoma:a pooled analysis from the International Lymphoma Epidemiology Consortium (Inter Lymph)显示文摘	Morton LM Hartge P Holford TR		0，，04：	1
8	Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate,Lung,Colorectal and Ovarian Cancer(PLCO)Screening Trial显示文摘	Trabert B Pinto L Hartge P	2014	Gynecol Oncol2014，135，29：	1
9	Genetics of reproductive lifespan 显示文摘	Hartge P	2009	Nat Genet2009，41，6：	1
10	Immunostaining to i-dentify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era显示文摘	Morton L M Cerhan J R Hartge P	2011	Int J Mol Epidemiol Genet2011，2，3：	1
11	Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence 显示文摘	HARTGE P DEVESA S S	1992	Cancer Res (Sup-pl)1992，52，：	1
12	Sun exposure,vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma显示文摘	Purdue MP Hartge P Davis S	2007	Cancer Causes Control2007，18，9：	1
13	Performance of common genetic variants in breast-cancer risk models 显示文摘	Wacholder S Hartge P Prentice R	2010	N Engl J Med2010，362，11：	1
14	Parity oral contraceptives and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation显示文摘	Modan B Hartge P Hirsh-Yechezkel G		0，，：	1
15	The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews显示文摘	Struewing JP Hartge P Wacholder S	1997	N Engl J Med1997，336，20：	1
16	Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, eolorectal and ovarian cancer (PLCO) screening trim 显示文摘	Trabert B Pinto L Hartge P et el	2014	Gynecol Oneol2014，135，2：	1
17	Epidemiology of bladder cancer显示文摘	Silverman DT Hartge P Morrison AS	1992	Hematol Oncol Clin North Am1992，6，1：	1
18	ABO blood group and the risk of pancreatic cancer显示文摘	WOLPIN B M CHAN A T HARTGE P	2009	J Natl Cancer Inst2009，101，6：	1
19	ABO blood group and the risk of pancreatic cancer显示文摘	Wolpin BM Chan AT Hartge P	2009	J Natl Cancer Inst2009，101，6：	1
20	Immunostain- ing to identify molecular subtypes of diffuse large B - cell lympho- ma in a population - based epidemiologic study in the pre - ritux- imab era显示文摘	MORTON L M CERHAN J R HARTGE P	2011	Int J Mol Epidemiol Genet2011，2，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示